Chimeric Capsid Protein as a Nanocarrier for siRNA Delivery: Stability and Cellular Uptake of Encapsulated siRNA

被引:84
作者
Choi, Kyung-mi [1 ]
Choi, Seung-Hye [1 ]
Jeon, Hyesung [1 ]
Kim, In-San [2 ]
Ahn, Hyung Jun [1 ]
机构
[1] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea
[2] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Taegu 700422, South Korea
基金
新加坡国家研究基金会;
关键词
capsid protein; siRNA delivery; nanocarrier; gene silencing; recombinant proteins; SMALL INTERFERING RNA; GENE DELIVERY; IN-VIVO; ELECTRON CRYOMICROSCOPY; SYNTHETIC SIRNAS; MAMMALIAN-CELLS; COATED PIT; VECTORS; EFFICIENT; CYTOTOXICITY;
D O I
10.1021/nn202597c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
For the efficient cytoplasmic delivery of siRNA, we designed a chimeric capsid protein composed of a capsid shell, integrin targeting peptide, and p19 RNA binding protein. This recombinant protein assembled into a macromolecular container-like structure with capsid shell and provided a nanocarrier for siRNA delivery. Our capsid nanocarriers had dual affinity both for siRNA within the interior and Integin receptors on the exterior, and the capsid shell structure allowed the encapsulated siRNAs to be protected from the external nucleases, leading to the enhanced stability of siRNA in serum conditions. The capsid nanocarriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. Moreover, RGD peptides on the exterior surface of the capsid shell enabled the capsid nanocarriers to deliver siRNA into the cytosol of the target cells. Here, we demonstrated the superior efficiency of our siRNA/capsid nanocarrier complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhancing the stability of siRNA as well as to achieving targeted siRNA delivery.
引用
收藏
页码:8690 / 8699
页数:10
相关论文
共 44 条
[1]   Nonviral delivery of synthetic siRNAs in vivo [J].
Akhtar, Saghir ;
Benter, Ibrahim F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3623-3632
[2]   Determination of the fold of the core protein of hepatitis B virus ky electron cryomicroscopy [J].
Bottcher, B ;
Wynne, SA ;
Crowther, RA .
NATURE, 1997, 386 (6620) :88-91
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[5]   siRNA function in RNAi: A chemical modification analysis [J].
Chiu, YL ;
Rana, TM .
RNA, 2003, 9 (09) :1034-1048
[6]   The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine [J].
Choi, Young-Suk ;
Lee, Jue Yeon ;
Suh, Jin Sook ;
Kwon, Young-Min ;
Lee, Seung-Jin ;
Chung, Jun-Key ;
Lee, Dong-Soo ;
Yang, Victor C. ;
Chung, Chong-Pyoung ;
Park, Yoon-Jeong .
BIOMATERIALS, 2010, 31 (06) :1429-1443
[7]   Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells [J].
Cooper, A ;
Shaul, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (04) :1094-1099
[8]   3-DIMENSIONAL STRUCTURE OF HEPATITIS-B VIRUS CORE PARTICLES DETERMINED BY ELECTRON CRYOMICROSCOPY [J].
CROWTHER, RA ;
KISELEV, NA ;
BOTTCHER, B ;
BERRIMAN, JA ;
BORISOVA, GP ;
OSE, V ;
PUMPENS, P .
CELL, 1994, 77 (06) :943-950
[9]   Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells [J].
Czauderna, F ;
Fechtner, M ;
Dames, S ;
Aygün, H ;
Klippel, A ;
Pronk, GJ ;
Giese, K ;
Kaufmann, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (11) :2705-2716
[10]  
Devroe E, 2004, EXPERT OPIN BIOL TH, V4, P319, DOI 10.1517/eobt.4.3.319.27320